January 18, 2022
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine – Jan 12, 2022
-- Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine granted approval in South Korea GAITHERSBURG, Md., Jan.…
January 12, 2022
Chain Drug Review Pharmacy Outlook: Ronald Piervincenzi, USP
January 10, 2022 by Ronald Piervincenzi The COVID-19 pandemic made the last year both an extraordinary and challenging time to…
January 12, 2022
Decentralized Clinical Trials Raise Concerns About Informed Consent
Under pressure of the COVID-19 pandemic, multitudes of clinical trials of new medications and treatments have moved to a decentralized…
January 10, 2022
REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subre…
ROCKVILLE, Md., Jan. 10, 2022 /PRNewswire/ -- ASCENTTM, a Phase III clinical trial conducted in partnership with AbbVie, is expected…
January 9, 2022
MIMETAS opens Phenotypic Screening Center
Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center.…
January 9, 2022
Are we witnessing the dawn of post-theory science? | Artificial intelligence (AI) | The Guardian
Isaac Newton apocryphally discovered his second law – the one about gravity – after an apple fell on his head.…
January 9, 2022
Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research
- Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment - ROCKVILLE, Md.--(BUSINESS WIRE)--Hibiscus BioVentures,…
January 7, 2022
NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to…